Clinical Features of Non-Squamous Non-Small-Cell Lung Cancer Patients Treated with Long-Term Pemetrexed

被引：0
|
作者：
Hirai, Kenichiro [1 ]
Yokouchi, Hiroshi [1 ]
Azuma, Keisuke [1 ]
Minemura, Hiroyuki [1 ]
Sekine, Satoko [1 ]
Kanazawa, Kenya [1 ]
Tanino, Yoshinori [1 ]
Munakata, Mitsuru [1 ]
机构：
[1] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Long-term; Beyond PD; pemetrexed; NS-NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-050
引用
收藏
页码：S420 / S420
页数：1
相关论文
共 50 条
  • [1] Clinical features of patients with advanced non-squamous non-small cell lung cancer treated with long-term pemetrexed
    Hirai, Kenichiro
    Yokouchi, Hiroshi
    Azuma, Keisuke
    Minemura, Hiroyuki
    Sekine, Satoko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 123 - 123
  • [2] PREDICTIVE FACTORS FOR LONG-TERM RESPONSE TO PEMETREXED TREATMENT IN ADVANCED NON-SQUAMOUS, NON-SMALL-CELL LUNG CANCER PATIENTS
    Kwon, J.
    Kim, Y. J.
    Lee, K.
    Yoon, H. I.
    Kim, J. H.
    Lee, J.
    Lee, C.
    Lee, J. S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S73 - S74
  • [3] CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
    Watanabe, K.
    Okuma, Y.
    Nakahara, Y.
    Yomota, M.
    Takagi, Y.
    Hosomi, Y.
    Okamura, T.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 86 - 86
  • [4] PHARMACOGENETIC STUDY IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Yasue, T.
    Hirashima, T.
    Kobayashi, M.
    Okamoto, N.
    Suzuki, H.
    Hosono, K.
    Morishita, N.
    Matsuura, Y.
    Tamiya, M.
    Shiroyama, T.
    Morita, S.
    Matsumoto, T.
    Morishita, H.
    Kawahara, K.
    Kawase, I.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 136 - 136
  • [5] Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
    Sojung Park
    Hyun Jung Kim
    Chang–Min Choi
    Dae Ho Lee
    Sang–We Kim
    Jung–Shin Lee
    Woo Sung Kim
    Se Hoon Choi
    Jin Kyung Rho
    Jae Cheol Lee
    [J]. BMC Cancer, 16
  • [6] Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
    Park, Sojung
    Kim, Hyun Jung
    Choi, Chang-Min
    Lee, Dae Ho
    Kim, Sang-We
    Lee, Jung-Shin
    Kim, Woo Sung
    Choi, Se Hoon
    Rho, Jin Kyung
    Lee, Jae Cheol
    [J]. BMC CANCER, 2016, 16
  • [7] Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
    Minami, Seigo
    Kijima, Takashi
    [J]. LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 13 - 25
  • [8] Pemetrexed for non-squamous non-small-cell lung cancer: experience in Northern Ireland
    Mulligan, C.
    Campbell, L.
    McAleese, J.
    Scullin, P.
    [J]. LUNG CANCER, 2011, 71 : S6 - S6
  • [9] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy in non-squamous non-small-cell lung cancer.
    Karayama, Masato
    Inui, Naoki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Yokomura, Koshi
    Koshimizu, Naoki
    Sato, Masaki
    Toyoshima, Mikio
    Shirai, Toshihiro
    Masuda, Masafumi
    Yamada, Takashi
    Imokawa, Shiro
    Suda, Takafumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer
    Xu, Bei
    Liu, Peng
    Yin, Yongmei
    Liu, Ping
    Shu, Yongqian
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769
12345